Indivior PLC (LON:INDV)
1,238.00
+19.00 (1.56%)
Inactive · Last trade price on Jul 24, 2025
Indivior Employees
As of December 31, 2024, Indivior had 1,051 total employees, including 1,030 full-time and 21 part-time employees. The number of employees decreased by 113 or -9.71% compared to the previous year.
Employees
1,051
Change (1Y)
-113
Growth (1Y)
-9.71%
Revenue / Employee
869.90K GBP
Profits / Employee
-46.10K GBP
Market Cap
1.54B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 1,051 | -113 | -9.71% | 1,030 | 21 |
| Dec 31, 2023 | 1,164 | 236 | 25.43% | 1,164 | 0 |
| Dec 31, 2022 | 928 | 43 | 4.86% | 928 | 0 |
| Dec 31, 2021 | 885 | 97 | 12.31% | 885 | 0 |
| Dec 31, 2020 | 788 | -8 | -1.01% | 788 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Indivior News
- 2 days ago - New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder - GlobeNewsWire
- 9 days ago - Indivior Pharmaceuticals Inc (INDV) Stock Price Up 2.7% on Mar 4 - GuruFocus
- 15 days ago - Decoding Indivior Pharmaceuticals Inc (INDV): A Strategic SWOT Insight - GuruFocus
- 15 days ago - Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program - Seeking Alpha
- 15 days ago - Indivior Pharmaceuticals, Inc. (INDV) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Indivior (INDV) Q4 2025 Earnings Call Transcript - The Motley Fool
- 15 days ago - Indivior Non-GAAP EPS of $0.82 beats by $0.15, revenue of $358M beats by $52.38M - Seeking Alpha
- 15 days ago - Indivior Plc. Reports Increase In Q4 Bottom Line - Nasdaq